• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用二甲基酮双胍腙的空气氧化动力学分光光度法测定铜(II)和吡啶

Kinetic-spectrophotometric determination of Cu(II) and pyridine by use of the aerial oxidation of dimedone bisguanylhydrazone.

作者信息

López F S, Nevado J J, Mansilla A E

机构信息

Department of Analytical Chemistry, Faculty of Sciences, University of Extremadura, Badajoz, Spain.

出版信息

Talanta. 1984 May;31(5):325-30. doi: 10.1016/0039-9140(84)80091-0.

DOI:10.1016/0039-9140(84)80091-0
PMID:18963605
Abstract

The synthesis and analytical properties of dimedone bisguanylhydrazone (DIBG) are described for the first time. DIBG is oxidized by aerial oxygen and the reaction is catalysed by copper(II). The catalytic effect of copper(II) is increased by the presence of pyridine. Kinetic methods are described for determining trace amounts of copper(II) and pyridine. The reaction is followed spectrophotometrically by measuring the rate of change of absorbance at 550 nm. The calibration graphs are linear in the range 0.6-9.5 mug for copper(II) and 0.2-8.8 mg for pyridine. The methods have been applied to the determination of copper in galena and of pyridine in piperidine and isoamyl alcohol. The kinetic parameters of the reaction have been determined.

摘要

首次描述了二甲双酮双胍腙(DIBG)的合成及分析特性。DIBG 可被空气中的氧气氧化,该反应由铜(II)催化。吡啶的存在会增强铜(II)的催化效果。描述了测定痕量铜(II)和吡啶的动力学方法。通过测量 550 nm 处吸光度的变化速率,用分光光度法跟踪该反应。铜(II)的校准曲线在 0.6 - 9.5 μg 范围内呈线性,吡啶的校准曲线在 0.2 - 8.8 mg 范围内呈线性。这些方法已应用于方铅矿中铜的测定以及哌啶和异戊醇中吡啶的测定。已确定了该反应的动力学参数。

相似文献

1
Kinetic-spectrophotometric determination of Cu(II) and pyridine by use of the aerial oxidation of dimedone bisguanylhydrazone.利用二甲基酮双胍腙的空气氧化动力学分光光度法测定铜(II)和吡啶
Talanta. 1984 May;31(5):325-30. doi: 10.1016/0039-9140(84)80091-0.
2
Kinetic spectrophotometric determination of nanogram levels of manganese by use of the salicylaldehyde guanylhydrazone-hydrogen peroxide system.
Talanta. 1987 Mar;34(3):321-4. doi: 10.1016/0039-9140(87)80039-5.
3
A kinetic method for the determination of copper(II) by its catalytic effect on the oxidation of 3-methyl-2-benzothiazolinone hydrazone with hydrogen peroxide: a mechanistic study.一种基于铜(II)对过氧化氢氧化3-甲基-2-苯并噻唑啉酮腙的催化作用测定铜(II)的动力学方法:机理研究
Anal Sci. 2005 Aug;21(8):917-22. doi: 10.2116/analsci.21.917.
4
Spectrophotometric determination of trace iron by using its catalytic effect on the N-phenylanthranilic acid-potassium periodate reaction.利用铁对N-苯基邻氨基苯甲酸-高碘酸钾反应的催化作用分光光度法测定痕量铁。
Anal Sci. 2008 May;24(5):595-9. doi: 10.2116/analsci.24.595.
5
Spectrophotometric kinetic determination of copper(II) trace amounts based on its catalytic effect on the reaction of the reduced 2,6-dichlorophenolindophenol and hydrogen peroxide.基于铜(II)对还原型2,6 - 二氯酚靛酚与过氧化氢反应的催化作用,用分光光度动力学法测定痕量铜(II)
Talanta. 1994 Oct;41(10):1645-9. doi: 10.1016/0039-9140(94)e0090-e.
6
[Study on determination of trace copper(II) by catalytic kinetic discoloring spectrophotometry].催化动力学褪色分光光度法测定痕量铜(II)的研究
Guang Pu Xue Yu Guang Pu Fen Xi. 2004 Jan;24(1):114-7.
7
Kinetic-spectrophotometric method for the determination of trace amounts of bromide in seawater.动力学分光光度法测定海水中痕量溴化物
Talanta. 2006 Jan 15;68(3):951-6. doi: 10.1016/j.talanta.2005.06.061. Epub 2005 Aug 11.
8
Kinetic spectrophotometric determination of nanogram amounts of cyanide.
Talanta. 1991 Mar;38(3):303-8. doi: 10.1016/0039-9140(91)80051-z.
9
Catalytic flow-injection determination of sub-ppb copper(II) using the redox reaction of cysteine with iron(III) in the presence of 2,4,6-tris(2-pyridyl)-1,3,5-triazine.
Anal Sci. 2003 May;19(5):731-5. doi: 10.2116/analsci.19.731.
10
Kinetic spectrophotometric method for the determination of norfloxacin in pharmaceutical formulations.动力学分光光度法测定药物制剂中的诺氟沙星。
Eur J Pharm Biopharm. 2004 Mar;57(2):359-67. doi: 10.1016/S0939-6411(03)00192-9.